Spyre Therapeutics
SYRE
#4522
Rank
C$2.46 B
Marketcap
$48.35
Share price
3.29%
Change (1 day)
209.77%
Change (1 year)

Spyre Therapeutics (SYRE) - Total debt

Total debt on the balance sheet as of December 2023 : N/A

According to Spyre Therapeutics's latest financial reports the company's total debt is N/A. A companyโ€™s total debt is the sum of all current and non-current debts.

Spyre Therapeutics - Total debt on balance sheet (from 2018 to 2023)

Total debt by year

Year Total debt Change
2023-12-31N/A-100%
2022-12-31C$6.28 M-2.6%
2021-12-31C$6.44 M-7.17%
2020-12-31C$6.94 M5.05%
2019-12-31C$6.61 M
2018-12-31N/A